Ever Source Wealth Advisors, LLC Rocket Pharmaceuticals, Inc. Transaction History
Ever Source Wealth Advisors, LLC
- $1.95 Billion
- Q2 2025
A detailed history of Ever Source Wealth Advisors, LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 1,599 shares of RCKT stock, worth $6,396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,599
Previous 223
617.04%
Holding current value
$6,396
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding RCKT
# of Institutions
220Shares Held
98.5MCall Options Held
611KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$70.8 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$33.5 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$24.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$24.5 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$19.3 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $303M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...